IMV Technologies

IMV Technologies

ANIMAL ARTIFICIAL REPRODUCTION BIOTECHNOLOGIES

“ IMV Technologies represents half a century of history in biotechnologies dedicated to assisted reproduction. The management team is pleased with its partnership with Qualium Investissement, which enables the Group to accelerate its strategy of product innovations and its international development in high growth markets such as Asia and Latin America "

 Philippe Gravier

 

Philippe GRAVIER

Chief Executive Officer

 

Founded in 1963 and based in L'Aigle, Normandy, IMV Technologies is a world leader in artificial insemination and reproduction biotechnologies.

IMV Technologies designs, manufactures and sells equipment and consumables used in the collection, packaging, cryopreservation, monitoring and insemination of animal semen from over 14 species. IMV Technologies has a respective 65% and 25% share of the global market for cattle and swine species, which represent its two main lines of business.

With six foreign subsidiaries (US, India, China, Italy, the Netherlands and Great-Britain), and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 80% of its revenue internationally.

The group has five production sites, the largest of which is in L'Aigle.

120
countries
350m straws110
€m revenue
485
employees

 Jacques PANCRAZI

Partner in charge

 

 

Investment date: 2014

TwitterLinked InFacebookEmail